Matthew Farrer, PhD, Imperial College

Affiliations: 
Neurogenetics and Translational Medicine University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Neurodegenerative diseases
Website:
http://www.cmmt.ubc.ca/research/investigators/farrer/lab
Google:
"Matthew Farrer"
Cross-listing: Neurotree

Children

Sign in to add trainee
Stefano Cataldi grad student 2014-pres UBC (FlyTree)
Igor Tatarnikov grad student 2015-pres UBC (FlyTree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gao Y, Wilson GR, Stephenson SEM, et al. (2018) The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society
Mishima T, Fujioka S, Tomiyama H, et al. (2017) Establishing diagnostic criteria for Perry syndrome. Journal of Neurology, Neurosurgery, and Psychiatry
Volta M, Beccano-Kelly DA, Paschall SA, et al. (2017) Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice. Elife. 6
Puschmann A, Fiesel FC, Caulfield TR, et al. (2017) Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. Brain : a Journal of Neurology
Wile DJ, Agarwal PA, Schulzer M, et al. (2017) Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. The Lancet. Neurology
Wang L, Heckman MG, Aasly JO, et al. (2016) Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study. Neurobiology of Aging
Puschmann A, Fiesel FC, Caulfield TR, et al. (2016) Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism. Brain : a Journal of Neurology
Gustavsson EK, Trinh J, Guella I, et al. (2016) DCTN1 p.K56R in progressive supranuclear palsy. Parkinsonism & Related Disorders
Guella I, Evans DM, Szu-Tu C, et al. (2016) α-synuclein genetic variability: A biomarker for dementia in Parkinson's disease. Annals of Neurology
Carr J, Guella I, Szu-Tu C, et al. (2016) Double homozygous mutations (R275W and M432V) in the ParkinGene associated with late-onset Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society
See more...